Clinical trial
Plasma Concentrations of Amoxicillin Administered in High-doses During the First Week of Treatment : Intra- and Inter-individual Variability, Factors Associated With Overdose and Adverse Events
NCT04070469 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Plasma Concentrations of Amoxicillin Administered in High-doses During the First Week of Treatment : Intra- and Inter-individual Variability, Factors Associated With Overdose and Adverse Events
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 4, 2019
- Completion date
- December 19, 2024
- Enrollment
- 142 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
infection, bacterial